Central Drugs Standard Control Organisation Archives

The test was first launched in 2022 and identified four major female-specific malignancies in a single blood test: breast, endometrium, cervix, and ovary

Health

Gurugram-based startup ‘PredOmix’ develops AI-based blood test to detect 32 cancers...

PGurus Newsdesk - April 13, 2023 1

OncoVeryx-F aids in determining the presence or absence of cancer as well as the tissue of origin or cancer type With 98 percent accuracy, a...

The expert panel of the CDSCO had recently approved antiviral drug Molnupiravir for restricted use in an emergency situation

COVID_19

Amid spike in COVID-19 cases, antiviral drug Molnupiravir launched in India

PGurus Newsdesk - January 4, 2022 0

Covid antiviral drug Molnupiravir launched in India The much-awaited antiviral pill against COVID-19, Molnupiravir was launched in India on Monday. Covid antiviral drug is priced...

Covaxin is now the second vaccine cleared for use for children in India

COVID_19

Covaxin gets a nod for emergency use for 12-18 age group...

PGurus Newsdesk - December 25, 2021 0

Covaxin gets emergency use approval for children aged between 12-18 years As Omicron cases surges in India, the Hyderabad-based vaccine manufacturer Bharat Biotech's Covaxin on...

Increasing the Covaxin shelf life helps reduce the carbon footprint, says the company

Health

Shelf life of Covaxin extended to 12 months from the date...

Team PGurus - December 20, 2021 1

Extended shelf-life for Covaxin helps lessen vaccine wastage The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's...